Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „tafamidis“
Suchtreffer
Begriffe & Kennungen
Vyndaqel · 4.5 · 3 daily doses of 61 mg tafamidis. Therefore, patients should be monitored for BCRP substrate related adverse r
Eintrag öffnenVyndaqel · 4.5 · In a clinical study in healthy volunteers, 20 mg tafamidis meglumine did not induce or inhibit the cytochrome
Eintrag öffnenVyndaqel · 4.5 · In a clinical study in healthy volunteers, 20 mg tafamidis meglumine did not induce or inhibit the cytochrome
Eintrag öffnenVyndaqel · 4.5 · In a clinical study in healthy volunteers, 20 mg tafamidis meglumine did not induce or inhibit the cytochrome
Eintrag öffnenVyndaqel · 4.5 · In vitro tafamidis inhibits the efflux transporter BCRP at the 61 mg/day tafamidis dose with IC50=1.16 µM and
Eintrag öffnenVyndaqel · 4.5 · In vitro tafamidis inhibits the efflux transporter BCRP at the 61 mg/day tafamidis dose with IC50=1.16 µM and
Eintrag öffnenVyndaqel · 4.5 · In vitro tafamidis inhibits the efflux transporter BCRP with IC50=1.16 µM and may cause drug-drug interactions
Eintrag öffnenVyndaqel · 4.5 · Likewise, tafamidis inhibits the uptake transporters OAT1 and OAT3 (organic anion transporters) with IC50=2.9
Eintrag öffnenVyndaqel · 4.5 · Likewise, tafamidis inhibits the uptake transporters OAT1 and OAT3 (organic anion transporters) with IC50=2.9
Eintrag öffnenVyndaqel · 4.5 · Likewise, tafamidis inhibits the uptake transporters OAT1 and OAT3 (organic anion transporters) with IC50=2.9
Eintrag öffnenVyndaqel · 4.5 · No interaction studies have been performed evaluating the effect of other medicinal products on tafamidis megl
Eintrag öffnenVyndaqel · 4.5 · No interaction studies have been performed evaluating the effect of other medicinal products on tafamidis.
Eintrag öffnenVyndaqel · 4.5 · No interaction studies have been performed evaluating the effect of other medicinal products on tafamidis.
Eintrag öffnenVyndaqel · 4.5 · Tafamidis may decrease serum concentrations of total thyroxine, without an accompanying change in free thyroxi
Eintrag öffnenVyndaqel · 4.5 · Tafamidis may decrease serum concentrations of total thyroxine, without an accompanying change in free thyroxi
Eintrag öffnenVyndaqel · 4.5 · Tafamidis may decrease serum concentrations of total thyroxine, without an accompanying change in free thyroxi
Eintrag öffnenVyndaqel · 4.8 · Safety data for tafamidis 61 mg are available from its open-label long-term extension study.
Eintrag öffnenVyndaqel · 4.8 · Safety data for tafamidis 61 mg are available from its open-label long-term extension study.
Eintrag öffnenVyndaqel · 4.8 · The following adverse events were reported more often in patients treated with tafamidis meglumine 80 mg compa
Eintrag öffnenVyndaqel · 4.8 · The following adverse events were reported more often in patients treated with tafamidis meglumine 80 mg compa
Eintrag öffnen